HEIDELBERG PHARMA
LIVE

Serial Number

88064933

Owner

Heidelberg Pharma AG

Attorney

Todd A. Sullivan

Filing Date

Aug 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

HEIDELBERG PHARMA Trademark

Serial Number: 88064933 • Registration: 6021542

HEIDELBERG PHARMA is a trademark filed by Heidelberg Pharma AG on August 3, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Heidelberg Pharma AG (2 trademarks)

Schriesheimer Strasse 101
68526 Ladenburg , DE

Entity Type: 99

Trademark Details

Filing Date

August 3, 2018

Registration Date

March 31, 2020

Published for Opposition

January 14, 2020

Goods & Services

Pharmaceutical preparations for the treatment of immuno oncological disorders, namely, cancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical preparations for human use, namely, for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use

Pharmaceutical advice; pharmaceutical services, namely, providing pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products

Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 31, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 4, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 4, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 4, 2025 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 5, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 5, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 5, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 12, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 12, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 12, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 12, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2019 CRFA
ASSIGNED TO LIE
Nov 16, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 26, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 26, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 26, 2018 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 10, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2018 NWOS
NEW APPLICATION ENTERED
Aug 7, 2018 NWAP